Study of NPF-08 in Patients Who Receive Colonoscopy
Status:
Completed
Trial end date:
2019-06-19
Target enrollment:
Participant gender:
Summary
To study non-inferiority of intestinal cleansing effect in both NPF-08 1-day treatment group
and NPF-08 2-day split dose group to the cleansing effect in Moviprep® 1-day treatment group,
for the subjects who will receive endoscopy large bowel. If the non-inferiority will be
validated, superiority of intestinal cleansing effect in both groups of NPF-08 will be
studied.
Furthermore, for the assessment of safety of NPF-08, the adverse events and adverse drug
reactions observed after the administration to post-examination period will be studied,
compared to those at Moviprep® 1-day treatment group.